The Journal of Critical Limb Ischemia (JCLI) will consider for publication suitable articles on topics pertaining to the study, management, and treatment of critical limb ischemia and acute peripheral artery disease.
Editorial Policies and Access. Statements and opinions expressed by authors are their own and not necessarily those of the publisher, editorial staff, or any member of the Editorial Advisory Board. The publisher of the Journal of Critical Limb Ischemia accepts no responsibility for statements made by contributors or claims made by advertisers, nor does the publication of advertisements constitute or imply endorsement. Manuscripts are accepted for publication in JCLI with the understanding that their content, all or in part, has not been published elsewhere and will not be published elsewhere, except in abstract form or by the express consent of the Managing Editor. Only those with substantial intellectual contributions should be included as an authors. Co-authors will receive an email prompting them to confirm their contributions to the submission. Each author should respond to the email via the appropriate link (“Yes, I am an author” or “No, I am not an author”). Authors may indicate multiple authors who contributed equally. In such cases, authors should include a notation on the title page regarding which authors contributed equally to the work. It is the responsibility of the authors, institutions, or third parties, to determine order of authorship, acknowledgments, and institutional affiliations.
All manuscripts submitted for publication must include the following statement signed by the senior author within the cover letter: “The undersigned author transfers all copyright ownership of the manuscript entitled (title of article) to HMP Global in the event the work is published. The author warrants that the article is original, is not under consideration by another journal, and has not been previously published. I sign for and accept responsibility for releasing this material on behalf of any and all co-authors.”
All articles will be freely accessible to the public immediately upon posting to the website. There is no processing fee for authors to publish in JCLI.
Best Practices. Manuscripts must conform to Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations). In addition, the Journal of Critical Limb Ischemia adheres to Committee on Publication Ethics (COPE) core practices (scholarly research and publications guidelines) as a guide to the highest standards in publication ethics. By submitting your manuscript to JCLI you agree to a plagiarism screen via iThenticate. All submissions will be screened for plagiarism before being reviewed by the peer-review panel.
Conflicts of Interest, Human and Animal Rights, Informed Consent. Authors are responsible for all content submitted. Opinions expressed by authors are their own and not necessarily those of HMP Global, the editorial staff, or any member of the editorial advisory board. No claims made by authors or advertisers are guaranteed by the publisher or the editors. Authors must comply with Food and Drug Administration guidelines, human studies guidelines and animal welfare regulations of the authors’ institution. Authors should indicate in the paper that human subjects have given informed consent and that the authors have conformed to institutional guidelines, including information about Institutional Review Board approval.
The Journal of Critical Limb Ischemia requires authors to disclose possible conflict of interest situations (financial or personal interests), real or apparent, that may affect or appear to affect the impartiality and the integrity of the peer review process. These include employment, financial benefit, and public advocacy. These disclosures do not necessarily exclude an article from consideration for publication; the goal of disclosure is transparency. Reviewers and editors are expected to follow these same standards and to recuse themselves from participating in the review of manuscripts relevant to such interests. For more information, consult the ICMJE financial disclosure policy.
A statement acknowledging financial interest in products/companies relevant to submitted research must be disclosed to the editors when the paper is submitted. Any financial interest that may be interpreted as a conflict of interest, including stock ownership, consultancies, patent-licensing relationships, and other equity interests, must be disclosed in the cover letter. If no conflicts of interest exist, this must be stated.
Peer Review Policy. All submissions are peer reviewed by 2 to 3 referees who are experts in the field. The Journal of Critical Limb Ischemia peer-review process is single-anonymized (single-blind). This is the most common form of peer review among science journals. Acceptance is based upon significance and originality. If an article is accepted for publication, the corresponding author will be notified via e-mail through Editorial Manager and the content revision requirements supplied by the peer reviewers will be included. Additional editorial revisions may be made to articles accepted as an aid to clarity. If an article is not accepted, the corresponding author will be notified by e-mail through Editorial Manager. To avoid significant delays in the peer review or editorial processing of your manuscript, please adhere to the submission guidelines.
Confidentiality. Editors and editorial staff will not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Misconduct. JCLI editors are dedicated to following best practices on ethical matters, errors, and retractions. Editors will take reasonable steps to identify and prevent publication of papers where research misconduct has occurred. Action taken will be in accordance with COPE guidelines. The editorial board does not tolerate plagiarism in any form, including (but not limited to) affiliation misrepresentation, breaches in copyright, use of third-party material without permissions, citation manipulation, duplicate submission/publication, image or data manipulation/fabrication, peer review manipulation, plagiarism, text-recycling/self-plagiarism, and undisclosed competing interests and/or unethical research.
Post Publication Discussion and Corrections. After an article has been published it may be necessary to make a change to the Version of Record. This will be done after careful consideration by the Editor in accordance with guidance from COPE. If a change is deemed necessary, it will be published with a statement that will be permanently linked to the original article, such as a correction notice, an Expression of Concern, Retraction, or Removal.
Manuscript Format. All submissions to the journal are submitted online in a digital format through Editorial Manager, a web-based, peer review system. Standard format for the initial submission is a MS Word document with embedded figures or a PDF. Please include a title page listing authors and institutions, along with any potential conflicts of interest. Manuscript should include a structured abstract, full text of manuscript, references, tables, legends, and figures. Separate pages are not required for different sections of the manuscript. Manuscripts are organized as follows: title page, abstract, introduction, methods, results, discussion, acknowledgments, references, tables, figure legends, and figures. videos if applicable.
Provide adequate line spacing and page numbers. Abbreviations should be defined at first mention. Please include a word count and number all pages. Line numbers are helpful for reviewers.
Article Length. The word limit is 5000 words or less (word count does not include references). There should generally be no more than 50 references. There should generally be no more than 5 tables and/or line drawings. There is no limit to images or videos if they add value to the article.
Publication. Upon acceptance, all articles will be copyedited and published on the JCLI website (https://www.clijournal.com). Authors will subsequently have the opportunity to review proofs and submit any corrections prior to final publication in a quarterly issue.
Editorial Manager. To log into our online manuscript submission website, you must first set up an author account. Please go to https://www.editorialmanager.com/clig/. After logging into your account, please make every effort to complete all fields within the submission form; all mandatory fields are indicated with an asterisk (*). After you have completed the submission form, you may browse/attach or drag text files and digital figures onto the submission page. These files will be converted to a PDF for use by reviewers. Figures must not include identifying patient information.
Corresponding Author/Additional Authors
• The corresponding author will receive all manuscript-related correspondence via email.
• NOTE: Authors are those who participated in manuscript preparation: conception, design, research and/or writing. Others who were consulted can be mentioned in the acknowledgments section.
• The senior author must be listed in the final publication as the corresponding author.
Title Page
• Include the manuscript’s title; a short title (≤50 characters) is optional, but helpful.
• Include all author(s) names, academic degrees, and institutions
• Disclosure statement. The title page should contain one of the disclosure statements listed below. Specific details of any conflicts of interest or financial relationships will be required at a later date according to ICMJE standards and detailed within the final published document:
(1) The authors report no financial relationships or conflicts of interest regarding the content herein.
(2) One or more of the authors have disclosed potential conflicts of interest regarding the content herein.
(3) One or more of the authors has disclosed a potential conflict of interest that is not financial in nature.
• Abstracts can be included on the title page or the next page.
Text/Tables
• Use generic drug names (even if trade names are mentioned).
• When products are mentioned, list the manufacturer.
• Obtain appropriate consent for quotations of more than 50 words.
Case Reports
Journal of Critical Limb Ischemia will consider case reports on a limited basis. Those considered will be first-in-man experiences or those considered novel with high teaching value. A substantial discussion should be included.
Abstract. An abstract is necessary for the review process. Depending on the type of article, it may or may not be published. For example, abstracts are not published for Review articles, Editorials, or Letters. For these types of articles, please provide a brief summary of less than 100 words for the review process. These summaries are emailed to manuscript reviewers to help them determine if they have the expertise or interest in reviewing the article in question. For original articles and research studies, please provide a structured abstract (objectives, methods, results, discussion, conclusions) less than 250 words.
Key Words. Please choose 2-3 words from within the submission template pulldown menu to be used in order to cross reference the subject of your manuscript with the expertise of the review board. Reviewers will be chosen based upon these selections.
References. References should be listed at the end of the manuscript. Numbered references must be cited, in order in the text. Use AMA reference style. References not properly formatted will be returned to authors for revision. A complete periodical reference includes 1) authors’ names (list all authors up to six, for 7 or more authors, list first 3 followed by et al.); 2) title of article (notice capitalization style); 3) abbreviated journal name; 4) year of publication; 5) volume number; 6) specific page numbers 7) doi number. For books include: 8) name of editor(s), if any; 9) place of publication, and (10) publishing company.
For example:
Periodical: List all authors up to 6; for 7 or more authors, list first 3 followed by et al.:
8. Hoyt T, Feldman MD, Okutucu S, et al. Assessment of vascular patency and inflammation with intravascular optical coherence tomography in patients with superficial femoral artery disease treated with Zilver PTX Stents. Cardiovasc Revasc Med. 2020;21(1):101-107. doi:10.1016/j.carrev.2019.07.009
Book:
5. Vidovich MI, Shroff A. Transradial Angiography and Intervention. From Simple to Spectacular. HMP Global, 2016.
Chapter in Book (author is not editor of the book):
5. Banerjee S, Brilakis ES. Peripheral artery intervention with combined use of atherectomy and drug-coated balloon. In: Shammas NW (ed). Textbook of Atherectomy. HMP Global, 2016: pp. 179-184.
Figure Legends/Copyright
• A descriptive legend must accompany each figure.
• All abbreviations must be identified in the figure legend. For example: Abbreviations: DM, diabetes mellitus; CTO, chronic total occlusion; PTA, percutaneous transluminal angioplasty.
• If a figure has been published previously, permission to reprint the figure must be obtained in writing from the copyright owner and submitted upon acceptance. Please acknowledge the original source beneath the figure.
Figures
• Photographs may be color (RGB or CMYK) or black & white.
• For review, figures can be in TIFF, PowerPoint, EPS, or png format (JPEGs must be embedded into the Word document).
• Limit panels to no more than 6 per single figure; limit white space between frames. Avoid headings and text within figures.
• Lower resolution (72 dpi) figures are usually adequate for the review process. In general, these are also usually suitable for online exclusive publication (300 dpi is standard quality for print production). However, line art (graphs, charts, text) is usually best when 800-1000 dpi. For final online publication it is usually best to use the best quality available since many readers will want to print your final article PDF.
Videos
.mP4 files are the preferred format.
For more information, contact Managing Editor Cynthia Laufenberg at: claufenberg@hmpglobal.com